Form 8-K - Current report:
SEC Accession No. 0001193125-22-196756
Filing Date
2022-07-19
Accepted
2022-07-19 10:38:36
Documents
13
Period of Report
2022-07-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d384811d8k.htm   iXBRL 8-K 27561
  Complete submission text file 0001193125-22-196756.txt   185779

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btmd-20220718.xsd EX-101.SCH 3905
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE btmd-20220718_def.xml EX-101.DEF 13677
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20220718_lab.xml EX-101.LAB 22583
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20220718_pre.xml EX-101.PRE 14639
7 EXTRACTED XBRL INSTANCE DOCUMENT d384811d8k_htm.xml XML 5322
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 221090673
SIC: 2833 Medicinal Chemicals & Botanical Products